6125 related articles for article (PubMed ID: 3498854)
1. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
Griffin TW; Childs LR; FitzGerald DJ; Levin LV
J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
[TBL] [Abstract][Full Text] [Related]
2. Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.
Levin LV; Griffin TW; Childs LR; Davis S; Haagensen DE
Cancer Immunol Immunother; 1987; 24(3):202-6. PubMed ID: 3496151
[TBL] [Abstract][Full Text] [Related]
3. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
4. Blocked and not blocked whole-ricin-antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude mice.
Brusa P; Pietribiasi F; Bussolati G; Dosio F; Arione R; Comoglio PM; Prat M; Cattel L
Cancer Immunol Immunother; 1989; 29(3):185-92. PubMed ID: 2659170
[TBL] [Abstract][Full Text] [Related]
5. Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects.
Kikuchi T; Ohnuma T; Holland JF; Spitler LE
Cancer Immunol Immunother; 1992; 35(5):302-6. PubMed ID: 1394334
[TBL] [Abstract][Full Text] [Related]
6. Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.
Iwahashi T; Tone Y; Usui J; Watanabe H; Sugawara I; Mori S; Okazaki H
Cancer Immunol Immunother; 1989; 30(4):239-46. PubMed ID: 2598192
[TBL] [Abstract][Full Text] [Related]
7. GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
Marszalowicz GP; Snook AE; Magee MS; Merlino D; Berman-Booty LD; Waldman SA
Oncotarget; 2014 Oct; 5(19):9460-71. PubMed ID: 25294806
[TBL] [Abstract][Full Text] [Related]
8. Production of a Granulysin-Based, Tn-Targeted Cytolytic Immunotoxin Using Pulsed Electric Field Technology.
Guerrero-Ochoa P; Aguilar-Machado D; Ibáñez-Pérez R; Macías-León J; Hurtado-Guerrero R; Raso J; Anel A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859066
[TBL] [Abstract][Full Text] [Related]
9. Selective cytotoxicity of a novel immunotoxin based on pulchellin A chain for cells expressing HIV envelope.
Sadraeian M; Guimarães FEG; Araújo APU; Worthylake DK; LeCour LJ; Pincus SH
Sci Rep; 2017 Aug; 7(1):7579. PubMed ID: 28790381
[TBL] [Abstract][Full Text] [Related]
10. Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.
Orlandi R; Canevari S; Conde FP; Leoni F; Mezzanzanica D; Ripamonti M; Colnaghi MI
Cancer Immunol Immunother; 1988; 26(2):114-20. PubMed ID: 3258791
[TBL] [Abstract][Full Text] [Related]
11. Immunotoxin sensitivity of Chinese hamster ovary cells expressing human transferrin receptors with differing internalization rates.
Recht LD; Raso V; Davis R; Salmonsen R
Cancer Immunol Immunother; 1996 Jul; 42(6):357-61. PubMed ID: 8830739
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma.
Webb KS; Liberman SN; Ware JL; Walther PJ
Cancer Immunol Immunother; 1986; 21(2):100-6. PubMed ID: 2418949
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes.
Vile R; Miller N; Chernajovsky Y; Hart I
Gene Ther; 1994 Sep; 1(5):307-16. PubMed ID: 7584096
[TBL] [Abstract][Full Text] [Related]
14. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
[TBL] [Abstract][Full Text] [Related]
15. The PTEN tumour suppressor gene and malignant melanoma.
Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
[TBL] [Abstract][Full Text] [Related]
16. Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants.
Carpenter LM; Swerdlow AJ; Fear NT
Occup Environ Med; 1997 Jun; 54(6):388-95. PubMed ID: 9245944
[TBL] [Abstract][Full Text] [Related]
17. T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas.
Lowes MA; Bishop GA; Crotty K; Barnetson RS; Halliday GM
J Invest Dermatol; 1997 Jun; 108(6):914-9. PubMed ID: 9182821
[TBL] [Abstract][Full Text] [Related]
18. Effects of thallium ion on cellular components of the skin.
Arbiser JL; Alani R; Flynn E; Wooten V; Byers HR
J Dermatol; 1997 Mar; 24(3):147-55. PubMed ID: 9114610
[TBL] [Abstract][Full Text] [Related]
19. Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.
van Golen KL; Risin S; Staroselsky A; Berger D; Tainsky MA; Pathak S; Price JE
Clin Exp Metastasis; 1996 Mar; 14(2):95-106. PubMed ID: 8605733
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation.
Rathanaswami P; Hachicha M; Wong WL; Schall TJ; McColl SR
Arthritis Rheum; 1993 Sep; 36(9):1295-304. PubMed ID: 8216423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]